Skip to main content

Table 1 Basic information of included studies for MMP-8 C-799 T, Lys460Thr, and Lys87Glu variants and overall cancer risk

From: MMP-8 C-799 T, Lys460Thr, and Lys87Glu variants are not related to risk of cancer

Author

Year

Origin

Cancer Type

Race

Source

Case

Control

Case

  

Control

 

P HWE

Method

Age range

 

NOS

C-799 T(rs11225395)

       

TT

TC

CC

TT

TC

CC

  

Case

Control

 

 Tsai

2018

Taiwan

Bladder cancer

Asian

PB

375

375

37

152

186

38

140

197

0.082

PCR-RFLP

mean 61.4

mean 62.9

7

 Hsiao

2018

Taiwan

Breast cancer

Asian

PB

1232

1232

118

466

648

131

468

633

0.002

PCR

NA

NA

7

 Pei

2017

Taiwan

Leukemia

Asian

PB

266

266

29

98

139

32

105

129

0.145

PCR-RFLP

mean 7.0

mean 8.3

7

 Shen

2017

Taiwan

Lung cancer

Asian

PB

358

716

40

130

188

92

273

351

0.001

PCR-RFLP

mean 64.0

mean 64.8

7

 Hung

2017

Taiwan

Oral cancer

Asian

PB

788

956

90

284

414

126

364

466

< 0.001

PCR

mean 55.8

mean 56.6

7

 Arechavaleta

2014

Mexico

Ovary cancer

Latin

HB

51

37

12

24

15

5

26

6

0.013

PCR-RFLP

49 (25–82)

39 (13–77)

7

 Wieczorek

2013

Poland

Bladder cancer

Caucasian

HB

241

199

44

125

72

38

101

60

0.697

RT PCR

66.3 ± 10.6

66.1 ± 10.4

8

 Srivastava

2013

India

Bladder cancer

Asian

HB

200

200

11

90

99

24

84

92

0.478

PCR-based

58.5 ± 12.4

56.8 ± 10.8

8

 Kim

2011

Korea

Gastric cancer

Asian

HB

148

315

14

67

67

38

127

150

0.172

GoldenGate

mean 57.8

mean 55.2

7

 Debniak

2011

Poland

MM

Caucasian

PB

296

290

58

152

86

43

134

113

0.750

TaqMan

mean 56.0

mean 55.0

8

 Qiu

2008

China Mainland

HCa

Asian

HB

417

480

81

196

140

80

216

184

0.223

PCR-RFLP

NA

NA

8

Lys460Thr

       

CC

CA

AA

CC

CA

AA

     

 Tsai

2018

Taiwan

Bladder cancer

Asian

PB

375

375

3

7

365

4

9

362

< 0.001

PCR-RFLP

mean 61.4

mean 62.9

7

 Hsiao

2018

Taiwan

Breast cancer

Asian

PB

1232

1232

7

26

1199

8

23

1201

< 0.001

PCR

NA

NA

7

 Pei

2017

Taiwan

Leukemia

Asian

PB

266

266

0

2

264

0

3

263

0.926

PCR-RFLP

mean 7.0

mean 8.3

7

 Shen

2017

Taiwan

Lung cancer

Asian

PB

358

715

0

3

355

0

4

711

0.940

PCR-RFLP

mean 64.0

mean 64.8

7

 Hung

2017

Taiwan

Oral cancer

Asian

PB

788

956

0

7

781

0

10

946

0.871

PCR

mean 55.8

mean 56.6

7

Lys87Glu

       

AA

AG

GG

AA

AG

GG

     

 Nan

2008

USA

Skin Cancer

Caucasian

PB

206

827

56

104

46

222

409

196

0.776

TaqMan

mean 63.4

mean 64.5

7

 Kader

2006

USA

Invasive BCa

Caucasian

HB

236

546

61

106

69

115

278

153

0.587

RT PCR

65 (21–88)

64 (24–89)

7

 Kader

2006

USA

Superficial BCa

Caucasian

HB

307

546

70

152

85

115

278

153

0.587

RT PCR

65 (21–88)

64 (24–89)

7

  1. HB hospital-based, HCa Hepatocellular carcinoma, BCa bladder cancer, MM Malignant melanoma, PB population-based, RT real time, PCR-RFLP polymerase chain reaction and restrictive fragment length polymorphism, NA not available, HWE Hardy-Weinberg equilibrium of controls